| pubmed-article:20951236 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20951236 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:20951236 | lifeskim:mentions | umls-concept:C0238598 | lld:lifeskim |
| pubmed-article:20951236 | lifeskim:mentions | umls-concept:C0015576 | lld:lifeskim |
| pubmed-article:20951236 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:20951236 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:20951236 | lifeskim:mentions | umls-concept:C1513882 | lld:lifeskim |
| pubmed-article:20951236 | lifeskim:mentions | umls-concept:C0206728 | lld:lifeskim |
| pubmed-article:20951236 | lifeskim:mentions | umls-concept:C0027831 | lld:lifeskim |
| pubmed-article:20951236 | lifeskim:mentions | umls-concept:C0679823 | lld:lifeskim |
| pubmed-article:20951236 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:20951236 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:20951236 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:20951236 | pubmed:dateCreated | 2010-12-14 | lld:pubmed |
| pubmed-article:20951236 | pubmed:abstractText | With increasing knowledge of the molecular pathways contributing to the progression of neurofibromatosis type 1 (NF1)-related plexiform neurofibroma (PN), the number of clinical trials for PNs has increased. However, little is known about the experiences of families with children with NF1 participating in clinical trials. | lld:pubmed |
| pubmed-article:20951236 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20951236 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20951236 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20951236 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20951236 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20951236 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:20951236 | pubmed:issn | 1559-2030 | lld:pubmed |
| pubmed-article:20951236 | pubmed:author | pubmed-author:WidemannBrigi... | lld:pubmed |
| pubmed-article:20951236 | pubmed:author | pubmed-author:WoltersPamela... | lld:pubmed |
| pubmed-article:20951236 | pubmed:author | pubmed-author:GillespieAndr... | lld:pubmed |
| pubmed-article:20951236 | pubmed:author | pubmed-author:MartinStaciS | lld:pubmed |
| pubmed-article:20951236 | pubmed:copyrightInfo | Published by Elsevier Inc. | lld:pubmed |
| pubmed-article:20951236 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20951236 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:20951236 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20951236 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20951236 | pubmed:pagination | 10-5 | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:meshHeading | pubmed-meshheading:20951236... | lld:pubmed |
| pubmed-article:20951236 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:20951236 | pubmed:articleTitle | Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer Institute. | lld:pubmed |
| pubmed-article:20951236 | pubmed:affiliation | Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. martins@mail.nih.gov | lld:pubmed |
| pubmed-article:20951236 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20951236 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| pubmed-article:20951236 | pubmed:publicationType | Research Support, N.I.H., Intramural | lld:pubmed |
